Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group
Year: 2003
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of Oncology
Authors: M. Martin, A. Villar, A. Sole-Calvo, R. Gonzalez, B. Massuti, J. Lizon, C. Camps, A. Carrato, A. Casado, M.T. Candel, J. Albanell, J. Aranda, B. Munarriz, J. Campbell, E. Diaz-Rubio
Institutions: Hospital Clínico San Carlos, Hospital Arnau de Vilanova, Vall d'Hebron Hospital Universitari, Hospital Universitario Reina Sofía, Hospital General Universitario de Alicante Doctor Balmis, Hospital Universitari Sant Joan D'Alacant, Hospital General Universitario De Valencia, Hospital General Universitario de Elche, Hospital Universitari i Politècnic La Fe, GEICAM – Spanish Breast Cancer Group
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2138440511
